Recommendation | Translation | Evaluation | ||||
No | Description | Agree, n (%) | Disagree | Neutral | SOR | Range |
1 | General principles for management | 21 (100) | 0 | 0 | 9.3 (0.9) | 7–10 |
2 | Disease monitoring | 20 (95) | 0 | 1 | 8.9 (1.3) | 6–10 |
3 | Management strategy | 20 (95) | 1* | 0 | 8.2 (2.6) | 0–10 |
4 | Non-drug treatment | 16 (76) | 4† | 1 | 7.2 (2.6) | 1–10 |
5 | Drug treatment: anti-inflammatory | 20 (95) | 0 | 1 | 8.3 (1.4) | 5–10 |
6 | Drug treatment: pain killers | 20 (95) | 0 | 1 | 8.8 (2.2) | 1–10 |
7 | Drug treatment: steroids | 21 (100) | 0 | 0 | 9.2 (0.9) | 7–10 |
8 | Drug treatment: DMARDs | 21 (100) | 0 | 0 | 9.0 (1.0) | 7–10 |
9 | Drug treatment: anti-TNF | 21 (100) | 0 | 0 | 8.9 (1.1) | 7–10 |
10 | Surgery | 20 (95) | 1‡ | 0 | 8.8 (1.4) | 6–10 |
1–10 | Overall agreement | 21 (100) | 0 | 0 | 8.7 (0.6) | N/A |
See box 1 for the text of the recommendations.
*Participant thinks that ankylosing spondylitis can be treated without medication in some cases; †participants think that the paragraph should be more positive, especially for physiotherapy and self-help groups; ‡participant thinks that a total hip replacement should not always be performed.
DMARDs, disease-modifying antirheumatic drugs; N/A, not applicable; SOR, strength of recommendation; TNF, tumour necrosis factor.